✦ LIBER ✦

Tumor Burden is Predictive of Survival in Patients With Non–Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib

✍ Scribed by Park, Jin Hyun; Kim, Tae Min; Keam, Bhumsuk; Jeon, Yoon Kyung; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog

Book ID: 122452667
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 448 KB
Volume: 14
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2012.10.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive and Prognostic Impact of Epid

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib

✍ Han, S.-W. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 132 KB

Mutations of the Epidermal Growth Factor

Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non-Small-Cell Lung Cancer With Postoperative Recurrence

✍ Mitsudomi, T. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 261 KB

Epidermal Growth Factor Receptor Gene Mu

Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non-Small-Cell Lung Cancer

✍ Takano, T. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 277 KB

Optimal Management of Patients with Non-

Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations

✍ Chia-Chi Lin, Dr James Chih-Hsin Yang 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 137 KB

Prospective phase II study of gefitinib

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations

✍ Sugio, Kenji; Uramoto, Hidetaka; Onitsuka, Takamitsu; Mizukami, Makiko; Ichiki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Epidermal growth factor receptor polymor

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib

✍ Liu, G; Gurubhagavatula, S; Zhou, W; Wang, Z; Yeap, B Y; Asomaning, K; Su, L; He 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB